LINC01647

Across TCGA pan-cancer cohorts, LINC01647 RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated LINC01647 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher LINC01647 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC01647 expression acts as an unfavorable survival marker, although some lineages such as SKCM show a favorable association.

BLCA, KIRP, and UVM are the cancer types where LINC01647 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Median	All	0.524	0.680	<.001	91	view →
KIRP	OS	Tertile	All	0.810	0.941	<.001	78	view →
UVM	DFS	Tertile	All	0.139	0.776	<.001	69	view →
KICH	OS	Tertile	All	0.866	0.982	<.001	69	view →
ACC	OS	Tertile	All	0.449	0.826	<.001	63	view →
HNSC	OS	Quartile	All	0.689	0.821	.001	54	view →
MESO	OS	Tertile	IV	0.036	0.602	<.001	42	view →
COAD	DFS	Tertile	All	0.613	0.806	.003	33	view →
TGCT	DFS	Median	II,III,IV	0.697	0.996	.017	30	view →
KIRC	OS	Tertile	All	0.444	0.648	.009	24	view →
PAAD	DFS	Tertile	III,IV	0.118	0.734	.014	18	view →
READ	OS	Tertile	IV	0.333	0.769	.002	18	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 18 lineages.

LINC01647–BLCA (DFS)

Open the BLCA breakdown →